Orari di ricevimento
Martedi ore 8:00-12:OO
Curriculum
CURRICULUM VITAE SOLMAZ ABDOLRAHIMZADEH
21/03/2020
PART I GENERAL INFORMATION
Full name: Solmaz Abdolrahimzadeh
Citizenship: Italian
Permanent residence: Rome, Italy
Email: solmaz.abdolrahimzadeh@uniroma1.it
solmazzadeh@gmail.com
Languages: Excellent: English, Italian, Persian
(Good understanding of French, Spanish)
PART II EDUCATION
High School Degree: 1981 International Baccalaureate Diploma (English), St Stephen’s School, Rome, Italy
University Degree: 1989 Medical Doctor (Laurea in Medicina e Chirurgia), University of Rome “Sapienza”, grade 110/110
Speciality Degree: 1994 Specialist in Ophthalmology (Diploma di Specializzazione in Oftalmologia), University of Rome “Sapienza”, grade: cum laude
Licensure: 1989 Licensed to practice medicine (Abilitazione all’esercizio della professione di medico chirurgo), Ministero dell’Università e della Ricerca Tecnologica, Rome
Licensure: 2011 Registered with a license to practice Medicine and the Speciality of Ophthalmology with the General Medical Council, UK
PhD (Dottorato di Ricerca) in Cell Biology 2016, Title of thesis “The role of optical coherence tomography (OCT) in retinal and choroidal pathology with a focus on intravitreal anti-vascular endothelial growth factor therapy”, University of Kent, United Kingdom
Abilitazione Scientifica Nazionale (national eligibility for associate professor) 27/07/2017 for the function of Professor of II Fascia, Settore Concorsuale 06/F2, Malattie Apparato Visivo (tornata 2016-2018)
PART III APPOINTMENTS
Specialist in Ophthalmology, Ophthalmic Emergency Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome (2001-2004)
Dirigente Medico -Consultant Specialist in Ophthalmology, Ophthalmology Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy (2004-Oct 2018).
Dirigente Medico - Consultant lead of the retina unit- UOC A, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy. Involved in morphofunctional study of choroid/retinal pathologies with near infrared reflectance and spectral domain optical coherence tomography with particular interest in rare diseases. Diagnosis and management of diabetic retinopathy, retinal vascular occulusion, age related and myopic macular degeneration. Laser treatment, intravitreal anti vascular endothelial growth factor treatment and intravitreal dexamethasone implantation. (2007-Oct 2018)
Appraisal in the role of “Dirigente Medico” (consultant)– “Valutazione finale del collegio tecnico”, DAI Testa/Collo, Azienda Ospedaliera Universitaria Policlinico Umberto I, Roma, on 15/1/2014: Excellent
Formal appointment - Particular Professional Qualification (Particolare Qualificazione Professionale – PQP) – “Medical retina and imaging.” Azienda Ospedaliera Universitaria Policlinico Umberto 1, Rome, Italy. Deliberation number 000735- 26/06/2017
Tenure Track Researcher type B (RTDB Ricercatore di tipo B) and Consultant Ophthalmologist (Dirigente Medico), Ophthalmology Unit, NESMOS Department, “Sapienza” University of Rome, Azienda Ospedaliera-Universitario Sant’Andrea, Rome, Italy
01/10/18- present
PART IV TEACHING EXPERIENCE, MEMBER OF EXAMINING BOARDS
Formal appointment as lecturer in “Medical contactology” School of Specialization in Ophthalmology, “Sapienza” University of Rome (Academic years: 2012/13, 2013/14, 2014/15, 2015/16)
Formal appointment as lecturer in “Ocular pathology associated with systemic disease”, School of Specialization in Ophthalmology, “Sapienza” University of Rome (Academic year 2016/2017- present)
Formal appointment as lecturer in Master I° Level “Assistance in Ophthalmology”: (Course code: 26142) Faculty of Medicine and Surgery, “Sapienza” University of Rome (Academic years: 2013/14 (22/3/14-21/2/15), 2014/15 (7/3/15-19/3/16), 2015/16 (18/3/16-11/3/17)
Formal appointment as lecturer in Master I° Level “Assistance in Ophthalmology”: (Codice corso: 26142) AA 2016/17, in the module “Surgery of the posterior segment”, Faculty of Medicine and Surgery, “Sapienza” University of Rome “Sapienza” (11/03/2017- present)
Member of examining board: School of Specialization in Ophthalmology, “Sapienza” University of Rome, Academic Year 2013/14
Member of examining board: School of Specialization in Ophthalmology, “Sapienza” University of Rome, Academic Year 2014/15
Member of examining board: Master of I° Livello “Assistance in Ophthalmology”, (cod. 26142) Faculty of Medicine and Surgery, “Sapienza” University of Rome, Academic year 2015/2016
Supervisor of final theses for residents of the School of Specialization in Opthalmology and Tutor for residents in Ophthalmology, “Sapienza” University of Rome, teaching carried out at Retina Center UOC A, Azienda Ospedaliera Universitaria Policlinico Umberto I, Roma.
2007-present
Formal appointment as PhD course lecturer in Neurosensorial Plasticity (collegio di docenti dottorato di ricerca plasticità neurosensoriale- identificativo 29523)- NESMOS Department, “Sapienza” Università di Roma
November 2018- present
Tutor for PhD student - PhD course “Plasticità Neurosensoriale” Ciclo XXXIV– (dottorato di ricerca- identificativo 29523)- NESMOS Department, “Sapienza” Università di Roma.
November 2018- present
Lecturer: MED 30 Sector, Ophthalmology, Faculty of Medicine and Psychology, “Sapienza” Università di Roma (October 2018 - present)
PART V SOCIETY MEMBERSHIPS
Italian Professional Board of Medical Doctors, Rome (Ordine dei Medici Chirughi di Roma) (Registration number – 433331) (1999-present)
General Medical Council (GMC) with licence to practice, United Kingdom (Registration number 7232661) (2011-present)
Specialist Registry of GMC with licence to practice, United Kingdom (Registration number 7232661) (2011-present)
Member of EURETINA (2020-present)
Member of Società Oftalmologica Italiana (SOI) (1994-presente)
Member of Società Oftalmologica Romana e del Lazio (2020-presente)
Member of The Association for Research in Vision and Ophthalmology (ARVO) (1997-2006 )
PART VI SCIENTIFIC RESPONSIBILITY, AND PARTICIPATION IN INTERNATIONAL AND NATIONAL RESEARCH PROJECTS, ADMITTED TO FUNDING ON THE BASIS OF COMPETITIVE CALLS AMONG PEERS
Winner and primary investigator of the grant project Progetto di Ateno, University of Rome Sapienza for the multicentric project entitled “Retinal and choroidal vascular and thickness alterations in patients with subretinal drusenoid deposits evaluated by optical coherence angiography” (prot. RP11916B7AC27CBC (Delibera del S.A. 300/19 - 26/11/2019)
(26/11/2019-present)
Investigator and winner of the grant project Progetto di Ateno University of Rome Sapienza entitled “ Retinal and choroidal vascular alterations as markers of endothelial damage in children with sleep respiratory disorders” (prot. RM120172AAA670C7)
(11/12/2020- present)
PART VII DIRECTION AND COORDINATION AND PARTICIPATION IN RESEARCH GROUPS APPROVED BY QUALIFIED PUBLIC INSTITUTIONS
Primary investigator in the multicentral project entitled” Retinal and choroidal vascular and thickness alterations in patients with subretinal drusenoid deposits evaluated by optical coherence tomography angiography -SDDA” University of Rome Sapienza, Azienda Ospedaliera Universitaria Sant’Andrea in collaboration with the Department of Ophthalmology, University Hospital Zurich. Prot.74SA_2020, RIF:CE 5749_2020 (06/06/2020- present)
Primary investigator in the project “Correlation between vascularized retinal layer thickness and choroidal thickness using optical coherence tomography-RVESC” . Azienda Ospedaliera Universitaria Policlinico Umberto I, University of Rome Sapienza, Prot. 4114/2016 (28/06/2016 -28/06/2017)
Primary investigator in the multicentric project “Ocular surface alterations following the intravitreal administration of the anti-vascular endothelial growth factor ranibizumab-SOTIV”. Azienda Ospedaliera Universitaria Policlinico Umberto I/ University of Rome Sapienza, in collaboration with the Istituto di Neurobiologia CNR, Italy, Prot. 3179/2014. (15/05/2014-15/05/2015)
Investigator in the project “Evaluation of the ganglion cell complex and macular vascularization with optical coherence tomography angiography in diabetic patients: dominant versus fellow eye- GVVOD” University of Rome Sapienza, Azienda Ospedaliera Universitaria Sant’Andrea. Prot. 184 SA_2020 RIF: CE 5750_2020 (30/09/2020- present)
Investigator in the project “Ganglion cell complex, vascular network and blood flow in early diabetic retinopathy in patients treated with citicoline drops -(GADR)” University of Rome Sapienza, Azienda Ospedaliera Universitaria Sant’Andrea. Prot. 157 SA_2020 RIF: CE 5602_2020 (09/09/2020 –present)
Investigator in the project “Macular blood vessel density alterations evaluated using spectral domain optical coherence tomography angiography following Ingestion of dark chocolate - MBIC”University of Rome Sapienza, Azienda Ospedaliera Universitaria Sant’Andrea. Prot. 84 SA_2020, RIF.CE 5606_2020
(03/06/2020 –present)
PART VIII PARTICIPATION IN RESEARCH GROUPS CHARACTERIZED BY NATIONAL AND INTERNATIONAL COLLABORATION
Investigator in the multicenter project “Randomized, Double-Blind, Placebo-Controlled, Three-Arm, 12-Month, Safety and Efficacy Study of Hydromethylthionine Mesylate (LMTM) Monotherapy in Subjects with Alzheimer’s Disease Followed by a 12-Month Open-Label Treatment”. Prot. TRx-237-039. EUDRACT 2017-003558-17
(10/12/2020- present)
Investigator in the multicentric project “ An observational study program to investigate the effectiveness of intravitreal aflibercept in diabetic macular edema and/or macular edema secondary to retinal vein occlusion in a real world stting AURIGA”, Roma, Sponsorized by Bayer, IMPACT study no° 19157
(05/03/2018- present)
Investigator in the multicentric study “ A 12 months, prospective, multicenter, open-label, single arm interventional study assessing the safety and tolerability of 0.5 mg ranibizumab in mono/bilateral wet AMD patients in eyes with BCVA below 2/10 and/or second affected eye ” Ranibizumab study prot. CRFB002AIT02, EUDRACT 2013-003333-15. (06/03/2014 - 17/01/2017)
Investigator in the multicentric study “NGFO212 (REPARO)/An 8-week phase I/II, multicentre, randomized, double-masked, vehicle controlled parallel group study with a 48 or 56 week follow-up period to evaluate the safety and efficacy of two doses (10ug/ml and 20ug/ml of recombinant human nerve growth factor eye drops solution versus vehicle in patients with Stage 2 and 3 of Neurotrophic Keratitis” Prot. NGF0212 Dompé (10/07/2014 - 04/11/2016)
Investigator in the multicentric study “Valutazione della prevalenza della Cheratite Neurotrofica nel diabete di tipo 1 e del tipo 2”, cod, RANK, in collaboration with the Università Campus Biomedico, Roma, sponsorized by Dompè Farmaceutici SpA
(25/09/2014 - 25/09/2015)
Investigator in the monocentric project “Studio di 2 settimane, randomizzato, controllato, a gruppi paralleli, in doppio cieco con 1 settimana successiva di osservazione per valutare la sicurezza, la tollerabilità e l’efficacia delle goccie oculari di lubricina (150ug/ml) verso gocce oculari di ialuronato di sodio (HA) 0,18% (Vismed) in pazienti affetti da occhio secco di grado moderato”, cod. LUB0115MD, sponsorized by Dompè Farmaceutici SpA (11/06/2015 - 23/06/2016)
Investigator in the multicentric project “Experimental and clinical evidence on the therapeutic role of Nerve Growth Factor in neurodegenerative ocular diseases”, cod. 20152EKSAY; PRIN 2015. (16/11/2016)
Participation in the research group, with international collaboration, at the Unità di Ematologia e Onclologia, III Clinica Medica, University of Rome Sapienza (01/09/1988 – 01/04/1991)
Participation in the research group at the Istituto Nazionale per lo Studio e la Cura dei Tumori, Divisione di Oncologia Sperimentale C, Milan (20/08/1990 - 14/09/1990)
Participation in the research group at the Histopathology Division, Queen Alexandra Hospital, Portsmouth, UK (30/07/2016- 24/08/2016)
PART IX FELLOWSHIPS
Fellowship for research in ophthalmology, Istituto Barraquer di Barcellona, Spain (15/09/1998 - 15/09/1999)
Fellowship for research in ophthalmology, Istituto Barraquer di Barcellona, Spain
(09/12/1999 - 09/12/2000)
PART X PARTICIPATION IN EDITORIAL BOARDS OF SCIENTIFIC JOURNALS, BOOKS, AND REVIEWER ROLES
Associate Editor for the section of Retina in BMC Ophthalmology, impact factor 1.600 (indexed in Scopus, Embase, Medline, Pubme, Pubmed central, Science Citation Index, SCImago, Current contents, Citebase, DOAJ, OAlster)
(28/03/18 - present)
Topic Editor for the International Journal of Molecular Sciences (IJMS) (ISSN 1422-0067; CODEN: IJMCFK; ISSN 1661-6596 for printed edition), impact factor 4.556; indexed in Web of Science, Scopus, Embase, Pubmed, PMC, DOAJ, Genomics JournalSeek, MEDLINE, Journal Citation Reports, Science Citation Index, Zetoc
(18/12/2020-present)
Guest Editor International Journal of Molecular Sciences impact factor 4.556, indexed in MEDLINE, PubMed, PubMed Central, EMBASE, CAS/Chemical Abstracts, CAB Abstracts, Scopus, Science Citation Index (SCI) Expanded, Current Contents
Special issue - Frontiers of molecular science and genomics in ophthalmic disease
(December 2020-present)
Editorial Board Member of Medicinski Glasnik (ISSN 1840-0132, eISSN 1840-2445) indexed in DOAJ, DRJI, EBSCO, Embase (Excerpta Medica), MEDLINE, Scopus
(14/03/17- present)
Guest Editor for the Journal of Clinical Medicine (JCM), (ISSN 2077-0383; CODEN: JCMOHK) (indexed in Impact factor 2019 3.303 indexed in Web of Science, Embase, Pubmed, PMC, Chemical Abstracts, DOAJ, Genomics JournalSeek, HINARI, Journal Citation Reports, Science Citation Index, Zetoc)
Special issue: Clinical advances in age-related macular degeneration
(18/12/2020 - present)
Editorial Board Member EC Ophthalmology – indexed in ProQuest, Index Copernicus, ICMJE, Google Scholar (27/02/17-present)
Editorial Board Member World Journal Ophthalmology (ISSN 2218 6239, DOI: 10.5318) - Baishideng Publishing Group Inc, Identification number (USA) 3537345
(08/09/12-05/06/18)
Exceptional reviewer:
Investigative Ophthalmology and Vision Science 2015, 2020
Reviewer in prestigious peer-reviewed international journals
British Journal of Ophthalmology, Investigative Ophthalmology and Visual Science, Retina, BMC Ophthalmology, Drugs and Aging, Biomedical Research International, Oncotarget, J Current Ophthalmology, EC Ophthalmology, Current Eye Research, Postgraduate Medicine, Seminars in Opphthalmology, QIMS (Quantitative Imaging in Medicine and Surgery), Experimental and Therapeutic Medicine, Plos One, J Glaucoma, J Int Medical Res,
Author of Book
“L’apparato oculare nelle sindromi neurocutanee.” Recupero SM, Abdolrahimzadeh S, Lepore GF, Contestabile MT, Pacella E. Verduci ed Roma, 2004
Author of chapter in book
“ Neurite ottica ishemica anteriore”. In Organi di Senso-Manuale per l’approccio integrato alle patologie testa-collo. Polimeni, De Vincentis, Lambiase, Valentini. Edra-Masson. Capitolo 7, pp 88-89, 2019
Author of chapter in book
“Papilledema”. In Organi di Senso-Manuale per l’approccio integrato alle patologie testa-collo. Polimeni, De Vincentis, Lambiase, Valentini. Edra-Masson. Capitolo 7, pp 93-95, 2019
Author of chapter in book
“Neovascular Glaucoma.” Balacco Gabrieli C, Pacella E, Abdolrahimzadeh S. In Pathophysiology of the Eye, 4. Glaucoma (ed.by J.Feher). Budapest: Akadémiai Kiado'. Ch. XI, pp. 211-225, 1998.
Participation in Editorial books:
Oftalmologia Clinica del Nord America (Ophthalmology Clinics of North America, WB Saunders Company-Philadelphia). Diagnostica per immagini in oftalmologia. Verduci ed, Roma, 1995.
Atlante di Oftalmologia. RK Parish II, Piccin Nuova Libreria, 2002
PART XI AWARDS AND ACKNOWLEDGEMENTS FOR SCIENTIFIC ACHIEVEMENT
Awarded “borsa di studio” for winning pubblico concorso per titoli e colloquio, Istituto Superiore di Sanità, D.D. 28/02/1997 and published on the Gazzetta Ufficiale, IV Serie Speciale, n.33, 29/04/1997” with DD 16/07/1998;
Awarded renewal of “borsa di studio”, of the Istituto Superiore di Sanità with DD 10/11/1999, in reference to the “borsa di studio” awarded on 16/07/1998;
Awarded “borsa di studio”: legge 30 Novembre 1989, n.398; Università di Roma Sapienza, Roma, (Academic year1989-1990);
Acknowledgment of “Editors Choice” for the article:
British Journal of Ophthalmology; articolo: Long-term results of intravitreal bevacizumab for choroidal neovascularisation in pathological myopia. British Journal Ophthalmol 2012; 96:1068-72.
PART XII PARTICIPATION AS SPEAKER, CO-SPEAKER, OR ORGANISATION - NATIONAL AND INTERNATIONAL SCIENTIFIC CONFERENCES
“Valutazione del rapporto tra frazione di incorporazione dei radionucleotidi e chemiosensibilità in vitro dei tumori del colon retto”. Congresso della Società Italiana di Cinetica Cellulare Applicata e di Base (SICCAB), Modena, 25-26th October, 1990.
“Ultrastructural immunolocalization of fibronectin in commercial pig cornea”. 5th Iranian Congress of Ophthalmology, Tehran, 26-30th November 1995.
“Lisch nodules in neurofibromatosis type 1. Relationship to age and cutaneous neurofibromas”. 5th Iranian Congress of Ophthalmology, Tehran, 26-30th November, 1995.
“The effect of the presence of blood on ferning of aqueous humor”. Presented at the Xth Congress European Society of Ophthalmology, Milano, 25-29th June, 1995.
“Influenza sulla felcizzazione dell’umore acqueo di alcuni liquidi impiegati per infusione in camera anteriore.” Atti del 75°Congresso SOI 1995:425. Roma.
“Excimer laser photorefractive keratectomy for high myopia and high myopic astigmatism”. Investigative Ophthalmology and Visual Science. March 15, 1997, vol 38, no.4, 1930-B723. ARVO Annual Meeting Fort Lauderdale, Florida, May 11-16, 1997.
“L'aumento della pressione intraoculare dopo cheratectomia photorefrattiva”. 78° Congresso SOI, 18-21 Nov.1998. Roma.
“Excimer laser photorefractive keratectomy for hyperopia and hyperopic astigmatism”. Investigative Ophthalmology and Visual Science 1999. Annual Meeting Fort Lauderdale, Florida, May 9-14, 1999.
“Visual Complaints after PRK”. Investigative Ophthalmology and Visual Science March 15, 2000, vol 41, no.4. ARVO Annual Meeting Fort Lauderdale, Florida April 30-May 5, 2000.
“Excimer laser surgery in ophthalmology. Ten years of experience”. Myopia and other disorders of refraction, accomodation and the oculomotor system. Proceedings of International Symposium. Moscow, Russia, Dec 18-20, 2001.
“Update sulla cheratectomia fotorefrattiva con il laser ad eccimeri: nostra esperienza”. XVII Congresso Annuale della Società Italiana Laser in Oftalmologia. Cortina d’Ampezzo 25-27 gennaio 2001.
“Excimer laser photorefractive keratectomy in the treatment of corneal scars and recurrent corneal erosion”. Investigative Ophthalmology and Visual Science Dec 2002, vol 43, 4245. ARVO Annual Meeting 2002, Fort Lauderdale, Florida.
“Superior bitemporal quadrantopia in the myopic eye: a tilted optic disc, case report. International Congress on Myopia and Related Diseases: a clinical approach”". VI Fondazione GB Bietti per lo studio e la ricerca in oftalmologia – ONLUS. International Congress Rome, Sept 24-27, 2003.
“Normal pressure” pseudotumor cerebri: a case report. Investigative Ophthalmology and Visual Science 2004 vol 45, 1609. ARVO Annual Meeting Fort Lauderdale, Florida May 2004.
Giornate di chirurgia orbito palpebrale”, Ospedale Sant’Andrea, Roma 3 dicembre 2005.
“Central 10° automated perimetry and contrast sensitivity in patients suffering from exudative macular degeneration before and after treatment with photodynamic therapy”. Investigative Ophthalmology and Visual Science May 2006, vol 47, 355. ARVO Annual Meeting Fort Lauderdale, Florida. April 30th-May 4th, 2006.
“Photorefractive keratectomy in the management of high myopic defects. Tissue saving versus Planoscan”. Investigative Ophthalmology and Visual Science 2006, vol 47, 3621. ARVO Annual Meeting Fort Lauderdale, Florida. April 30th-May 4th, 2006.
“Semiotica Oculare: Attualità e Prospettive”. Centro Congressi Piazza di Spagna, Roma 29 - 31 marzo 2007.
“Ipovisione e informatica”. IAPB, Roma, 24 ottobre 2008
“Il danno endoteliale”. Centro Congressi Ospedale Sant’Andrea, Roma, 11 ottobre 2008.
“La diagnosi differenziale e la scelta terapeutica in oftalmologia”. Centro Congressi Piazza di Spagna, Roma, 2-4 aprile 2009.
“La diagnosi e terapia del glaucoma: aquisizioni recenti”. Clinico Oculistica, Università di Roma, 8 giugno 2012.
“Ipovisione, fra ambito clinico, medico legale e vita quotidiana”, Clinica Oculistica, Policlinico Umberto I, Roma, 1 febbraio 2014
“Edema maculare diabetico up to date , nuove prospettive”. Moderatore, Urgenze oftalmologiche: dalla diagnosi alla terapia update. Ospedale Umberto I, Roma, 22 Ottobre 2015.
Spessori retiniche nelle strie angiodi corr. “Spectral domain optical coherence evidence of retinal and choroidal alterations in neurofibromatosis type 1”. Glaucoma vs Retina: Presente e futuro dell’oculista. 25-26 5° Congresso Pontino di Oftalmologia. 25-26 Settembre 2015, SS Cosmo e Damiano, LT, Italia
“Rotture retiniche acute: ruolo del vitreo”. Urgenze oftalmologiche dalla diagnosi alla terapia. CNR. Roma 24 Ottobre 2014.
“La Cornea”. Aula Magna Clinica Oculistica, Azienda Ospedaliero Universitario Policlinico Umberto I, Roma, 20 ottobre 2016.
“Fattori di crescità nelle degnerazioni retiniche “, XVIII Congresso Nazionale GIVRE, Genova, Italy, 8-10 June, 2017
“Disgenesie del segmento posteriore o anteriore” 8° Congresso Nazionale AIMO, Rome, Italy, 26-27 October 2017.
“Topical bromfenac for intraretinal edema associated with exudative age related macular degeneration”, 6th International Congress on OCT Angiography and advances in OCT, Rome, December 14-15th 2018
“Choroidal and retinal layer thickness alterations in early AMD associated with subretinal drusenoid deposits”. FloRetina, Florence, Italy, June 6-9, 2019.
“Imaging of choroidal hemangioma and evaluation of choroidal and outer retinal layer thickness using spectral domain optical coherence angiography in Sturge Weber syndrome”. 19th Congress of the European Society of Retinal Specialists (Euretina). Le Palais de Congrés, Paris, France, September 5-9, 2019.
“Angio OCT Vs FAG” Tavola Rotonda. ° Congresso Oculistico in Terra Pontina and 3° Retinitaly. Terracina, Italy, October 11/12, 2019.
“Neuroprotection, glaucoma from biology to patient”. Roma, Italy, November 15th 2019.
“La correlazione tra l’acutezza visiva e gli spessori retinici e coroideali, maculari e peripapillari nella miopia elevata “ 99° Congresso Nazionale SOI, Sessione 15, Rome, Italy 20-23 November 2019
“Macular ganglion cell layer thickness alterations in patients with neovascular age-related macular degeneration undergoing intravitreal antivascular endothelial growth factor therapy” Euretina Virtual 2020, 2-4 October 2020
“Alterazioni dello spessore dello strato delle cellule ganglionari in pazienti con degenerzione maculare essudativa in pazienti in trattamento con anti-VEGF” 100° Congresso Nazionale SOI 25-28 November 2020, Rome, Italy
“Long-term follow up of adult patient with NF1 with retinal neural proliferation using spectral domain optical coherence tomography” European Neurofibromatosis Virtual Meeting 2020, 10-12 December 2020, (Rotterdam, The Netherlands)
“Retinal microvascular and choroidal vessel abnormalities and their correlation with choroidal nodules in neurofibromatosis type 1.” 6TH SAN RAFFAELE OCT & RETINA FORUM. Virtual Congress (April 9, 23, 30 2021) Abstract accettato code 106287.
“Three dimensional model of the microvascular network obtained by using optical coherence tomography angiography in fovea plana and normal foveal depression.” 6TH SAN RAFFAELE OCT & RETINA FORUM. Virtual Congress (April 9, 23, 30 2021) Abstract accettato code AIM2A31.
PART XIII CLINICAL ACTIVITY
Residency: training and experience in all areas of ophthalmology. Work based at the major teaching hospital - University of Rome Sapienza (Azienda Ospedaliera Universitaria Sant’Andrea and Azienda Ospedaliera Universitaria Policlinico Umberto I) with extensive experience in all areas of ophthalmic care in a hospital environment.
2001 - 2004: specialist at the ophthalmic emergency unit of the Institute of Ophthalmology, Azienda Ospedaliera Universitaria Policlinico Umberto I, University of Rome Sapienza.
2004 - 2007: consultant ophthalmologist, involved in the ophthalmic ward activities and responsible for the post surgical unit at the Ophthalmology, Azienda Ospedaliera Universitaria Policlinico Umberto I, University of Rome Sapienza.
2007 - 2018: consultant ophthalmologist, responsible for the retina centre (UOCA) of the Ophthalmology Unit, Azienda Ospedaliera Universitaria Policlinico Umberto I.
Activity: clinical examinations and imaging. Pathologies: diabetic retinopathy, retinal vascular occlusion, age-related macular degeneration, other vitreo-retinal and choroidal pathologies. Treatment: retinal laser treatment (retinal tears, diabetic retinopathy, and post vascular occlusion ischemia), intravitreal injection treatment with anti-VEGF and steroid implants.
Further: diagnosis and management of the ophthalmic manifestations of rare diseases: neurocutaneous diseases, neurofibromatosis type 1, Sturge Weber syndrome, Klippel Trenaunay syndrome, von Hippel Lindau syndrome, phakomatoses pigmentovascularis etc.
October 2018 - present: consultant ophthalmologist and tenure track researcher (RTDB) at the Ophthalmology Unit of the Sant’ Andrea Hospital, Sapienza University of Rome, Faculty of Medicine and Psychology, Rome, Italy
December 2020- present: consultant ophthalmologist responsible for the Medical Retina unit of Ophthalmology, Sant’Andrea Hospital, Sapienza University of Rome, Faculty of Medicine and Psychology, Rome, Italy.
Activity: clinical examinations, near infrared reflectance imaging, spectral domain optical coherence tomography, fluorescein/indocyanine green angiography, autofluorescence imaging, optical coherence tomography angiography. Pathologies: diabetic retinopathy, retinal vascular occlusion, age-related macular degeneration, other vitreo-retinal and choroidal pathologies including rare diseases. Treatment: retinal laser treatment (retinal tears, diabetic retinopathy, and post vascular occlusion ischemia), intravitreal injection treatment with anti-VEGF and steroid implants.
Surgical capacity: anterior segment cataract surgeon
PART XIV RESEARCH ACITIVITY AND SUMMARY OF SCIENTIFIC ACHIEVEMENTS
Total scientific achievement (April 2021)
Total number of scientific publications: 91
Total number of international papers (scopus): 71
Total number of national papers: 12
Total number of books/book chapters: 4
Total Hirsh (H) index (scopus): 19
Total number of citations (scopus): 752
Total impact factor (calculated from JCR-Web of Science, based on year of publication): 115.6011
Scientific Publications
1) Formisano M, Di Pippo MC, Scuderi L, Abdolrahimzadeh S. Current concepts on diffuse choroidal hemangioma in Sturge Weber syndrome. Ophthalmic Genetics. Epub ahead of print doi: 10.1080/13816810.2021.1910963 (impact factor 1.308)
2) Fragiotta S, Ciancimino C, Perdicchi A, de Paula A, Abdolrahimzadeh S, Scuderi G.
Volume-rendering of angiographic optical coherence tomography angiography in fovea plana and normal foveal pit. Front Neurol doi: 10.3389/fneur.2021.633492 (impact factor 2.889)
3) De Paula A, Abdolrahimzadeh S, Fragiotta S, Di Pippo MC, Scuderi G. Current concepts on ocular vascular abnormalities in the phakomatoses. Seminars in Ophthalmology (DOI: 10.1080/08820538.2021.1900284) (impact factor 1.330)
4) Abdolrahimzadeh S, Formisano M, Scuderi L, Rahimi S. Long-term follow-up of adult patient with neurofibromatosis type 1 with retinal astrocytic hamartoma using spectral-domain optical coherence tomography: a review of the literature and a report of a case. Ophthalmic genetics. 2020 Nov 17:1-7. Doi 10.1080/13816810.2020.1849315. (Online ahead of print) (impact factor 1.308)
5) Abdolrahimzadeh S, Pugi DM, de Paula A, Scuderi G. Ocular manifestations in phakomatosis pigmentovascularis: current concepts on pathogenesis, diagnosis, and management. Surv Ophthalmol 2020 Oct 13:S0039-6257(20)30140-5: doi 10.1016/j.survophthal.202010.002. (online ahead of print) (Impact factor 4.195)
6) Abdolrahimzadeh S, Formisano M , Guglielmelli F, Amodeo S, Costa MC, Scuderi G Unusual case of indolent choroidal alterations mimicking neurofibromatosis type 1. Case Rep Ophthalmol 2020; 11:167-173.
7) Scuderi G, Ciancimino C, D’Apolito F, Maurizi Enrici M, Guglielmelli F, Scuderi L, Abdolrahimzadeh S. Short-term effects of dark chocolate on retinal and choriocapillaris perfusion in young healthy subjects using optical coherence tomography angiography. Nutrients 2020; 12:664. Doi:10.3390/nu12030664, (Impact factor 4.171)
8) Abdolrahimzadeh S, Fameli V, Di Tizio F, Di Staso F, Fenicia V, Scuderi G. The effect of topical bromfenac on intraretinal and subretinal fluid in exudative age-related macular degeneration. J Curr Ophthalmol 2020;32:203-6.
9) Di Staso F, Ciancaglini M, Abdolrahimzadeh S, D’Apolito F, Scuderi G. Optical coherence tomography of choroid in common neurological diseases. In Vivo 2019;33:1403-1409. (Impact factor 1.609)
10) Cipollini V, Abdolrahimzadeh S. Troili F, De Carolis A, Calafiore S, Scuderi L, Giubilei F, Scuderi G. Neurocognitive assessment and retinal thickness in Alzheimer’s disease: is there a correlation. J Neuro-Ophhtalmol 2020;40:370-377. DOI: 10.1097/WNO.0000000000000831. (Impact factor 2.509)
11) Scuderi G, Scuderi L, Calfiore S, Fenicia V, Abdolrahimzadeh S. Deep topical anesthesia with ropivacaine-soaked sponge for phacoemulsification. Int Ophthalmol 2019 May 31. Doi: 10.1007/s10792-019-01132-6 (Epub ahead of print). (Impact factor 1.335)
12) Abdolrahimzadeh S, Gharbiya M, Formisano M, Bertini F, Cerini A, Pacella E.
Anti-vascular endothelial growth factor intravitreal therapy and macular ganglion cell layer thickness in patients with neovascular age-related macular degeneration. Curr Eye Res 2019;22:1000-1005.
13) Abdolrahimzadeh S, Parisi F, Marcelli M, Giustolisi R, Gharbiya M. Optical coherence tomography evidence of macular ganglion cell-inner plexiform layer thinning in eyes with subretinal drusenoid deposits. Eye (Lond) 2019; 33 (8):1290-1296. (Impact factor 2017 2.478)
14) Formisano M, Abdolrahimzadeh B, Mollo R, Bruni P, Malagola M, Abdolrahimzadeh S. Bilateral diffuse choroidal hemangioma in Sturge Weber syndrome: A case report highlighting the role of multimodal imaging and a brief review of the literature. J Curr Ophthalmol 2018; 31(2):242-249. doi: org/10/1016/j.joco.2018.10.001
15) Gharbiya M, Giustolisi R, Marchiori J, Bruscolini A, Mallone F, Fameli V, Nebbioso M, Abdolrahimzadeh S. Comparison of short-term choroidal thickness and retinal morphological changes after intravitreal anti-VEGF therapy with ranibizumab or aflibercept in treatment naïve eyes. Curr Eye Res 2018; 43:391-396. (Impact factor 2017 2.120)
16) Abdolrahimzadeh S, Parisi F, Plateroti AM, Evangelista F, Fenicia V, Scuderi G, Recupero SM. Visual acuity, and macular and peripapillary thickness in high myopia. Curr Eye Res 2017; 42:1468-1473. (Impact factor 2.12)
17) Abdolrahimzadeh S, Parisi F, Mantelli F, Perdicchi A, Scuderi G. Retinal pigment epithelium-photoreceptor layer alterations in a patient with Sturge Weber syndrome with diffuse choroidal hemangioma. Ophthalmic Genetics, 2017; 6:567:569. (Impact factor 1.574)
18) Abdolrahimzadeh S. Choroidal thickness, correlations, and systemic disease. Surv Ophthalmol 2016; 62:250-251. (Impact factor 3.374 )
19) Perdicchi A, Abdolrahimzadeh S, Cutini A, Ciarnella A, Scuderi G. Evaluation of the progression of visual field damage in patients suffering from early manifest glaucoma. Clinical Ophthalmology 2016; 10:1647-1651.
20) Abdolrahimzadeh S, Parisi F, Abdolrahimzadeh B, Cruciani F. Unusual choroidal vessels in neurofibromatosis type 1 observed with near infrared reflectance and spectral domain optical coherence tomography. Acta Ophthalmologica 2016; 94: e815-e816. (Impact factor 3.157)
21) Abdolrahimzadeh S, Plateroti AM, Recupero SM, Lambiase A. An update on the ophthalmologic features in the phakomatoses. J Ophthalmol 2016. Article ID 3043026, doi: doi.org/10.1155/2016/3043026. (Impact factor 1.712)
22) Calafiore S, Perdicchi A, Scuderi G, Contestabile MT, Abdolrahimzadeh S, Recupero SM. Glaucoma management in carotid cavernous fistula. Case Reports in Ophthalmology 2016; 7:296-302.
23) Abdolrahimzadeh S, Piraino DC, Scavella V, Abdolrahimzadeh B, Cruciani F, Gharbiya M, Recupero SM. Spectral domain optical coherence tomography and B-scan ultrasonography in the evaluation of retinal tears in acute, incomplete posterior vitreous detachment. BMC Ophthalmol 2016 May 23; 16:60. (Impact factor 1.586)
24) Scuderi G, Abdolrahimzadeh S, Troccola A, Mazzocchi M, Recupero SM. Surgical treatment of a rare case of bilateral ptosis due to localized ocular amyloidosis. Saudi J Ophthalmol 2016; 30:201-203.
25) Abdolrahimzadeh S, Parisi F, Scavella V, Recupero SM. Optical coherence tomography evidence on the correlation of choroidal thickness and age with vascularized retinal layers in normal eyes. Retina 2016; 36(12): 2329-2338. (Impact factor 3.700)
26) Abdolrahimzadeh S, Plateroti P, Scarinci F, Plateroti AM. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion. Acta Ophthalmol 2016; 94 (8): e810-e811. (Impact factor 3.157)
27) Abdolrahimzadeh S, Scavella V, Battaglia D, Recupero SM. Spectral domain optical coherence tomography of choroidal and outer retinal layer thickness in the Sturge Weber syndrome. Curr Eye Res 2016; 41: 1614-1617. (Impact factor 2.238)
28) Mantelli F, Bruscolini A, La Cava M, Abdolrahimzadeh S, Lambiase A. Ocular manifestations of Sturge Weber Syndrome: pathogenesis, diagnosis and management. Clin Ophthalmol 2016 May 13;10:871-8.
29) Rahimi S, Lambiase A, Brennan PA, Abdolrahimzadeh S. An androgen receptor positive carcinoma of the lacrimal drainage system resembling salivary duct carcinoma: case report and review of the literature. Applied Immunohistochemistry & Molecular Morphology 2016; 24(8): e69-e71. (Impact factor 1.634)
30) Abdolrahimzadeh S, Piraino DC, Plateroti R, Scuderi GL, Recupero SM. Ocular alterations in a rare case of segmental neurofibromatosis type 1 with a non-classified mutational variant of the NF1 gene. Ophthalmic Genetics 2016; 37:214-216. (Impact factor 1.277)
31) Plateroti P, Plateroti AM, Abdolrahimzadeh S, Scuderi GL. Pseudoexfoliation syndrome and pseudoexfoliation glaucoma: a review of the literature with updates on surgical management. J Ophthalmol 2015. Article ID: 370371. (Impact factor 1.463)
32) Abdolrahimzadeh S, Scavella V, Felli L, Cruciani F, Contestabile MT, Recupero SM. Ophthalmic alterations in the Sturge Weber Syndrome, Klippel Trenaunay Syndrome and the Phakomatosis Pigmentovascularis: an independent group of conditions? Biomed Res Int vol 2015, Article ID 786519, 11 pages, 2015. Doi: 10.1155/2015/786519. (Impact factor 2.134)
33) Abdolrahimzadeh S, Fameli V, Mollo R, Contestabile MT, Perdicchi A, Recupero SM . Rare diseases leading to childhood glaucoma: epidemiology, pathophysiogenesis and management. Biomed Res Int vol 2015, Article ID 781294, 11 pages. doi: 10.1155/2015/781294. (Impact factor 2.134)
34) Abdolrahimzadeh S, Felli L, Plateroti AM, Perdicchi A, Contestabile MT, Recupero SM. Spectral domain optical coherence tomography evidence of retinal nerve fibre layer and ganglion cell loss in adult patients with neurofibromatosis type 1. Retina 2016; 36:75-81. (Impact factor 3.700)
35) Fenicia V, Abdolrahimzadeh S, Scuderi G , Fabrizio L, Maurizi Enrici M, Cruciani F, Recupero SM. Intracameral epinephrine without the addition of intracameral lidocaine in the management of tamsulosin associated intraoperative floppy iris syndrome. Clinica Terapeutica 2015;166:158-161. (Impact factor in 2013 0.329)
36) Abdolrahimzadeh S, Fenicia V, Maurizi Enrici M, Plateroti P, Cianfrone D, Recupero SM. Twelve-month results of a single or multiple dexamethasone intravitreal implant for macular edema following uncomplicated phacoemulsification. Biomed Res Int 2015;2015:362564. Doi: 10.1155/2015/362564. (Impact factor 2.134)
37) Mantelli M, Abdolrahimzadeh S, Mannino G, Lambiase A. Unusual case of angle closure glaucoma in a patient with neurofibromatosis type 1. Case Rep Ophthalmol 2014;5386-391.
38) Abdolrahimzadeh S, Felli L, Plateroti R, Plateroti AM, Giustini S, Calvieri S, Recupero SM. Morphologic and vasculature features of the choroid and associated choroid-retinal thickness alterations in neurofibromatosis type 1. Br J Ophthalmol 2015;99:789-793. (Impact factor 3.036)
39) Perdicchi A, Peluso G, Iacovello D, Balestrieri M, Delle Fave M, Abdolrahimzadeh S, Scuderi G, Fenicia V, Recupero SM. Ganglion cell complex evaluation in exudative age-related macular degeneration after repeated intravitreal injections of ranibizumab. Biomed Res Int 2015.2015:268796. Doi 10.1155/268796. Epub 2015 Jun 8. (Impact factor 2.134)
40) Abdolrahimzadeh S, Felli L, Piraino DC, Mollo R, Calvieri S, Recupero SM. Retinal microvascular abnormalities overlying choroidal nodules in neurofibromatosis type 1. BMC Ophthalmol 2014, 14:146. (Impact factor 1.020)
41) Fenicia V, Abdolrahimzadeh S, Mannino G, Verrilli S, Balestrieri M, Recupero SM. Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series. Eye 2014; 28:888-91. (Impact factor 2.082)
42) Lambiase A, Abdolrahimzadeh S, Recupero SM. An update on intravitreal implants in use for eye disorders. Drugs of Today 2014; 50: 239-49. (Impact factor 1.197)
43) Gharbiya M, Parisi F, Cruciani F, Bozzoni-Pantaleoni F, Pranno F, Abdolrahimzadeh S. Intravitreal antivascular endothelial growth factor for retinal angiomatous proliferation in treatment-naive eyes: long term functional and anatomical results using a modified PrONTO-style regimen. Retina 2014; 34:298-305. (Impact factor 3.243)
44) Gharbiya M, Cruciani F, Cuozzo G, Parisi F, Russo P and Abdolrahimzadeh S. Macular thickness changes evaluated with spectral domain optical coherence tomography after uncomplicated phacoemulsification. Eye 2013; 27:605-11. (Impact factor 1.897)
45) Abdolrahimzadeh S. Importance of vision screening in children regardless of socioeconomic status. Eye 2012;26:478. (Impact factor 1.818)
46) Gharbiya M, Cruciani F, Parisi F, Cuozzo G, Altimari S, Abdolrahimzadeh S. Long-term results of intravitreal bevacizumab for choroidal neovascularisation in pathological myopia. Br J Ophthalmol 2012; 96:1068-72. (Impact factor 2.725)
47) Carlesimo S, Abdolrahimzadeh S, Di Sanro L, Mazzeo F Semeiotica oftalmologica in pazienti affetti da distiroidismo: nostra esperienza. Clinica Terapeutica 2012; 163:e 397-400. (Impact factor 0.328)
48) Cruciani F, Abdolrahimzadeh S, Vicari A, Amore FA, Di Pilo S, Mazzeo L. Causes of blind certification in an Italian province and comparison with other European countries. Clinica Terapeutica 2010; 161: e 11-6. (Impact factor 0.257)
49) Abdolrahimzadeh S, Garzione F, Cruciani F, Rahimi S. Incidental finding of double nodular microscopic hyperplasia versus adenoma of the retinal pigment epithelium in an eye eviscerated for phthisis bulbi. Clinica Terapeutica 2010; 161:449-51. (Impact factor 0.257)
50) Pacella E, Abdolrahimzadeh S, Mollo R , Mazzeo L, Pacella F, Mazzeo F, Balacco Gabrieli C. Photorefractive keratectomy in the management of refractive accommodative esotropia in young adult patients. J Cataract Refract Surg 2009; 35:1873-1877. (Impact factor 2.745)
51) Cruciani F, Lorenzatti M, Nazzaro V, Abdolrahimzadeh S. Bilateral acute angle closure glaucoma and myopia induced by topiramate. Clinica Terapeutica 2009 160:215-216. (Impact factor in 2008 0.350)
52) Recupero SM, Perdicchi A, Fenicia V, Medori EM, Abdolrahimzadeh S, Scuderi G. Valutazione mediante metodiche psicofisiche di pazienti affetti da degenerazione maculare senile prima e dopo terapia fotodinamica. Ottica Fisiopatologia 2008; 2 (Giugno): 139-147.
53) Amore F, Pacella E, Pacella F, Abdolrahimzadeh S et al. Normal pressure pseudotumor cerebri:a case report. ARVO Investigative Ophthalmology and Visual Science 2004. Volume 45, Supplement 1:U588-U588 (Impact factor 3.577)
54) Recupero SM, Abdolrahimzadeh S, Lepore GF, Contestabile MT, Pacella E. L’apparato oculare nelle sindromi neurocutanee. Monografia. Verduci ed Roma, 2004.
55) Pacella E, Abdolrahimzadeh S, Pacella F, Mollo R, Villani GM, Balacco Gabrieli C. Phototherapeutic keratectomy in the treatment of corneal scars and in reccurent corneal erosion. ARVO Investigative Ophthalmology and Visual Science 2002. Volume 43, Supplement 2:U1201-U1201 (Impact factor 4.091)
56) Rahimi S, Onetti Muda A, Abdolrahimzadeh A, Recupero SM. Ultrastructural immunolocalization of fibronectin in Descemet’s membrane of commercial pig cornea. Ann Ophthalmol 2002; 34:15-18. (Impact factor 0.086)
57) Pacella E, Pacella F, Abdolrahimzadeh S, Basile M, Di Genova L, Panichi A, Brauneis S, Collini S. Efficacia della clonidina nella chirurgia oftalmica d’urgenza. Boll Ocul 81 2002; 81, n. 5/6:49-54.
58) Contestabile MT, Recupero SM, Suppressa F, Palladino D, Di Stefano M, Abdolrahimzadeh S, Balacco Gabrieli C. A new method of biofeedback in the management of low vision. Eye 2002;16 (4):472-80. (Impact factor 1.208)
59) Pacella E, Abdolrahimzadeh S, Mollo R, Giorgi D, Manaco P, Balacco Gabrieli C. Studio comparativo di due anti-infiammatori non steroidei somministrati dopo cheratectomia fotorefrattiva con il laser ad eccimeri: Indometacina 0.1% versus diclofenac sodico 0.1%. Boll Ocul 2001;80:483-491
60) Mannino G, Malagola R, Abdolrahimzadeh S, Villani GM, Recupero SM. Ultrasound biomicroscopy of degenerative retinoschisis and allied alterations of the ciliary body. Br J Ophthalmol 2001;85:976-982. (Impact factor 1.942)
61) Pacella E, Abdolrahimzadeh S, Balacco Gabrieli C. Excimer laser photorefractive keratectomy for hyperopia. Ophthalmic Surgery and Lasers 2001; 32:30-34. (Impact factor 0.745)
62) Abdolrahimzadeh S, Pacella F, Bisantis E, Pacella E. Diagnosi precoce e terapia del retinoblastoma:concetti attuali. Oftalmologia Sociale 2000 Anno XXIII n.2: 14-17.
63) S.Abdolrahimzadeh, E.Pacella, P.Morgia, L.Prencipe, F.Pacella, C.Balacco Gabrieli. Visual complaints after PRK. ARVO 2000. 41,4 :S920. Fort Lauderdale, Florida. Investigative Ophthalmology and Visual Science 2000. Volume 41, Issue 4. Supplement S, Pages S920-S920. (Impact factor 4.374)
64) Pacella E, Abdolrahimzadeh S, Giorgi D, Giustolisi R, Gharbiya M, Balacco Gabrieli C. Excimer laser photorefractive keratectomy for hyperopia and hyperopic astigmatism. ARVO Investigative Ophthalmology and Visual Science 1999, Volume 40, Issue 4:S781-S781. (Impact factor 4.858)
65) Abdolrahimzadeh S. La sospensione al frontale : un metodo chirurgico molto efficace nella ptosi. Oftalmologia Sociale Anno XXII, n°1 (Gennaio/Marzo) 1999.
66) Recupero SM, Abdolrahimzadeh S, DeDominicis M, Mollo R, Carboni I, Rota L, Calmieri S. Ocular alterations in alopecia areata. Eye 1999;13:643-646. (Impact factor 0.852)
67) Balacco Gabrieli C, Pacella E, Abdolrahimzadeh S, Regine F, Mollo R. Excimer laser photorefractive keratectomy for high myopia and myopic astigmatism. Ophthalmic Surgery and Lasers 1999; 30,6:442-448. (Impact factor 0.681)
68) Abdolrahimzadeh S, Pacella E, Lepore GF, Mollo R. Lesioni Retiniche in pazienti HIV positivi: correlazioni cliniche. Oftalmologia Sociale 1999 Anno XXII, 3, luglio-settembre.
69) Balacco Gabrieli C, Pacella E, Abdolrahimzadeh S. Neovascular Glaucoma. In Pathophysiology of the Eye, 4. Glaucoma (ed.by J.Feher).Budapest: Akadémiai Kiado'. Ch. XI, pp. 211-225, 1998.
70) Recupero SM, Appolloni R, Polli NSA, Abdolrahimzadeh S, Antonnicola G, Pierallini A. Papilloedema and hydrocephalus in spinal cord ancient schwannoma. Boll Ocul 1998;77,1:17-24.
71) Recupero SM, Abdolrahimzadeh S, DeDominicis M, Mollo R. Sturge-Weber syndrome associated with nevus of Ota. Eye 1998;12:212-213. (Impact factor 0.875)
72) Recupero SM, Mollo R, Abdolrahimzadeh S, Occhiuto A, Tripodi G.
Branch Retinal artery occlusion in a young woman with Meniere’s disease. Ophthalmologica 1998;212:77-79. (Impact factor 0.484)
73) Balacco Gabrieli C, Pacella E, Abdolrahimzadeh S, Cruciani F, Mollo R. Excimer laser photorefractive keratectomy for high myopia and high myopic astigmatism. ARVO Investigative Ophthalmology and Visual Science.1997, Volume 38, Issue 4: 1930. (5.250)
74) Recupero SM, Leucci E, Contestabile MT, Abdolrahimzadeh S, Mollo R. The effect of the presence of blood on ferning of aqueous humor. Boll Ocul 1997;76,3:519-525.
75) Barraquer J, Lepore GF, Moramarco A, Abdolrahimzadeh S, Giustolisi R, Angarano G. Aspettativa di vita media e curve di sopravivenza nei pazienti HIV positivi con diverse condizioni vascolari. Boll Ocul 1997;76,3:433-442.
76) Pacella E, Leopardi S, Abdolrahimzadeh S, Stalfieri M, Mollo R, Balacco Gabrieli C. Terapia topica antiglaucomatosa: revisione della letteratura e prospettive terapeutiche. Boll Ocul 1997;76,5:713-723.
77) Martini A, Abdolrahimzadeh S, Rosati C, Stalfieri M, Mollo R. Ruolo dell’oftalmologo nella diagnosi precoce di AIDS in occasione di screening di massa. Boll Ocul 1997;76,4:655-659.
78) Feher J, Recupero SM, Abdolrahimzadeh S and Balacco Gabrieli C. Structural evidence for membrane lipid changes in human cataract. Acta Ophthalmologica Scandinavica 1996,74:5996. (Impact factor 0.465 of 1997)
79) Balacco Gabrieli C, Recupero SM, Contestabile MT, Pacella E, Abdolrahimzadeh S. Fox's modified technique in the management of blepharoptosis. Ophthalmic Surgery and Lasers 1996; 27:1-5. (Impact factor 0.321 of 1997)
80) Lepore GF, Moramarco A, Pacella E, Barbati B, Abdolrahimzadeh S, Pupparo S, Martini A. Importanza della fluorangiografia nella valutazione clinica del paziente con infezione da HIV. Boll Ocul 1996; 75,3:537-543.
81) Recupero SM, Plateroti R, Abdolrahimzadeh S, De Dominicis M, Giustini S, Noviello MR, Calvieri S. Lisch nodules in neurofibromatosis type 1. Relationship to age and cutaneous neurofibromas. Ann Ophthalmol 1996; 28:178-183. (Impact factor 0.074 of 1997)
82) Contestabile MT, Plateroti R, Galasso C, Abdolrahimzadeh S, Delorenzi G, Rosa F. Peters' anomaly associated with central spastic palsy. Journal of Pediatric Ophthalmology and Strabismus 1995; 32:395-96. (Impact factor 0.575 of 1997)
83) Recupero SM, Lepore GF, Plateroti R, Abdolrahimzadeh S. Optic nerve aplasia associated with macular atypical coloboma. A case report. Acta Ophthalmologica Scandinavica 1994; 72:6. (Impact factor 0.465 of 1997)
84) Cruciani F, Tamanti N, Abdolrahimzadeh S, Franchi F and Balacco Gabrieli C. Ocular toxicity of systemic chemotherapy with megadoses of carmustine and Mitomycin C. Ann Ophthalmol 1994; 26, 3:97-100. (Impact factor 0.074 of 1997)
85) Recupero SM, Milano C, Cruciani F, Milano CA, Sceratti E, Paganelli G, Abdolrahimzadeh S. Efficacy of clinical, surgical and parasurgical treatment in subjects affected by initial or frank glaucoma (5 year follow up). Ann Opthalmol 1994; 16:52-53. (Impact factor 0.074 of 1997)
86) Recupero SM, Contestabile MT, Leucci E, Plateroti R, De Bella F, Abdolrahimzadeh S. Ferning of aqueous humor in the pseudoexfoliation syndrome. Acta Ophthalmologica Scandinavica 1993; 71:699-702. (Impact factor 0.465 of 1997)
87) Cruciani F, Barduagni F, Innocenzi D, Tamanti N, Abdolrahimzadeh S and Barduagni O. Ocular and cutaneous manifestations of pseudoxanthoma elasticum: a case report. Clinica Oculistica e patologia Oculare 1992; 3:132-36.
88) Recupero SM, Cruciali F, Picardo V, Sposato P, Tamanti N, Abdolrahimzadeh S. Hyperbaric oxygen therapy in the treatment of secondary keratoendotheliosis. Ann Ophthalmol1992; 24:448-452. (Impact factor 0.075 of 1997)
89) Seminara P, Franchi F, Abdolrahimzadeh S, Gozzer M, Barone C. Cancer associated hemolytic-uremic syndrome with spontaneous resolution. Tumori 1991; 77:181-184. Italy
90) Seminara P, Franchi F, Codacci Pisanelli G, Aronne T, Abdolrahimzadeh S. Discolouration of the nails and early anemia after Mitoxantrone, folinic acid and 5-Fluorouracil. Medical Oncology and Tumor Pharmacotherapy 1990; 7,4:291-92.
91) Seminara P, Franchi F, Codacci-Pisanelli G, Abdolrahimzadeh S, Aronne T, Afeltra A, Bonomo L. Evoluzione clinica e instabilità fenotipica in quattro casi di Mieloma multiplo: un modello della biologia nei tumori. Medicina 1989; 9/2,179.